Contemporary Reviews in Interventional Cardiology Cardiovascular Devices and Platelet Interactions Understanding the Role of Injury, Flow, and Cellular Responses

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

  2011cited by this paper
• Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.

  2011cited by this paper
• Hemodynamics and In-stent Restenosis: Micro-CT Images, Histology, and Computer Simulations

  2011cited by this paper
• Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.

  2011cited by this paper
• Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound.

  2011cited by this paper
• Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes.

  2011cited by this paper
• High-dose atorvastatin treatment in patients with peripheral arterial disease: Effects on platelet aggregation, blood rheology and plasma homocysteine

  2011cited by this paper
• Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

  2011cited by this paper
• Statins have an early antiplatelet effect in patients with acute myocardial infarction

  2011cited by this paper
• Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.

  2011cited by this paper
• Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions.

  2011cited by this paper
• The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents.

  2011cited by this paper
• Calcium modulates force sensing by the von Willebrand factor A2 domain

  2011cited by this paper
• Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel.

  2011cited by this paper
• Clinical ResearchInterventional Cardiology: Editorial CommentThe Magic of Disappearing Stents⁎

  2011cited by this paper
• Platelets: pleiotropic roles in atherogenesis and atherothrombosis.

  2010cited by this paper
• Design Optimization of a Mechanical Heart Valve for Reducing Valve Thrombogenicity—A Case Study with ATS Valve

  2010cited by this paper
• Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study

  2010cited by this paper
• Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype.

  2010cited by this paper
• The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.

  2010cited by this paper
• Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.

  2010cited by this paper
• Device Thrombogenicity Emulator (DTE)--design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designs.

  2010cited by this paper
• Intracoronary Eptifibatide Bolus Administration During Percutaneous Coronary Revascularization for Acute Coronary Syndromes With Evaluation of Platelet Glycoprotein IIb/IIIa Receptor Occupancy and Platelet Function: The Intracoronary Eptifibatide (ICE) Trial

  2010cited by this paper
• Towards Non-thrombogenic Performance of Blood Recirculating Devices

  2010cited by this paper
• Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation.

  2010cited by this paper
• Distribution and magnitude of shear stress after coronary bifurcation lesions stenting with the classical crush technique: a new predictor for in-stent restenosis.

  2010cited by this paper
• Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region.

  2010cited by this paper
• Stent Thrombosis in Sweden: A Report From the Swedish Coronary Angiography and Angioplasty Registry

  2009cited by this paper
• Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor

  2009cited by this paper
• Variability of platelet aggregate dispersal with glycoprotein IIb–IIIa antagonists eptifibatide and abciximab

  2009cited by this paper
• Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

  2009cited by this paper
• Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

  2009cited by this paper
• Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor

  2009cited by this paper
• Existence of a microRNA pathway in anucleate platelets

  2009cited by this paper
• Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials.

  2009cited by this paper
• Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study

  2008cited by this paper
• Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity.

  2008cited by this paper
• Biological effects of dynamic shear stress in cardiovascular pathologies and devices

  2008cited by this paper
• Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.

  2008cited by this paper
• Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.

  2008cited by this paper
• Hemodynamic parameters regulating vascular inflammation and atherosclerosis: a brief update.

  2008cited by this paper
• Numerical simulation of the dynamics of a bileaflet prosthetic heart valve using a fluid-structure interaction approach.

  2008cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• The growing complexity of platelet aggregation.

  2007cited by this paper
• Platelet function monitoring in patients with coronary artery disease.

  2007cited by this paper
• Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice.

  2007cited by this paper
• Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization

  2007cited by this paper
• Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

  2006cited by this paper
• Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

  2006cited by this paper
• Thrombogenic Performance of a St. Jude Bileaflet Mechanical Heart Valve in a Sheep Model

  2006cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.

  2006cited by this paper
• Reduced thrombus stability in mice lacking the α2A-adrenergic receptor

  2006cited by this paper
• Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

  2006cited by this paper
• Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.

  2005cited by this paper
• Short-Term Treatment With Atorvastatin Reduces Platelet CD40 Ligand and Thrombin Generation in Hypercholesterolemic Patients

  2005cited by this paper
• Importance of Temporal Flow Gradients and Integrin αIIbβ3 Mechanotransduction for Shear Activation of Platelets*

  2005cited by this paper
• Shear Stress Directly Regulates Platelet αIIbβ3 Signaling.

  2005cited by this paper
• Molecular Basis of Restenosis and Drug-Eluting Stents

  2005cited by this paper
• Role of platelets in the development of atherosclerosis.

  2004cited by this paper
• Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow.

  2004cited by this paper
• Impact of strut thickness on late luminal loss after coronary artery stent placement.

  2004cited by this paper
• Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

  2004cited by this paper
• Flow-Induced Platelet Activation in Bileaflet and Monoleaflet Mechanical Heart Valves

  2004cited by this paper
• Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study

  2004cited by this paper
• Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins

  2003cited by this paper
• P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.

  2003cited by this paper
• Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates.

  2002cited by this paper
• A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation

  2002cited by this paper
• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor.

  2002cited by this paper
• Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse

  2002cited by this paper
• Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin αIIbβ3

  2002cited by this paper
• Point-of-care measurement of platelet function before angioplasty strongly predicts future target vessel revascularization

  2002cited by this paper
• Distinct Glycoprotein Ib/V/IX and Integrin αIIbβ3-dependent Calcium Signals Cooperatively Regulate Platelet Adhesion under Flow*

  2002cited by this paper
• Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries

  2001cited by this paper
• Platelet Reactivity Characterized Prospectively: A Determinant of Outcome 90 Days After Percutaneous Coronary Intervention

  2001cited by this paper
• Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial

  2001cited by this paper
• Localized reduction of atherosclerosis in von Willebrand factor-deficient mice.

  2001cited by this paper
• Recombinant Soluble P-Selectin Glycoprotein Ligand-1-Ig Reduces Restenosis Through Inhibition of Platelet-Neutrophil Adhesion After Double Angioplasty in Swine

  2001cited by this paper
• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

  2001cited by this paper
• Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model.

  2001cited by this paper
• Roles of P-Selectin in Inflammation, Neointimal Formation, and Vascular Remodeling in Balloon-Injured Rat Carotid Arteries

  2000cited by this paper
• Acute platelet inhibition with abciximab does not reduce in-stent restenosis.

  2000cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

  2000cited by this paper
• Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators.

  1999cited by this paper
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

  1998cited by this paper
• Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin.

  1996cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

  1994cited by this paper
• Chapter 2 Fluid dynamic and hemorheologic considerations

  1993cited by this paper
• Fluid Dynamic and Hemorheologic Considerations

  1993cited by this paper
• Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis.

  1993cited by this paper
• The restenosis paradigm revisited: an alternative proposal for cellular mechanisms.

  1992cited by this paper
• Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.

  1991cited by this paper
• Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

  1988cited by this paper
• Studies on the Mechanisms of Shear-Induced Platelet Activation

  1987cited by this paper

• Atrial fibrillation increases thrombogenicity of LVAD therapy

  2024cites this paper
• Lagrangian Trajectory Simulation of Platelets and Synchrotron Microtomography Augment Hemodynamic Analysis of Intracranial Aneurysms Treated with Embolic Coils.

  2021cites this paper
• Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices

  2021cites this paper
• MICELI (MICROFLUIDIC ELECTRICAL IMPEDANCE): OPTIMIZATION OF AN ELECTRICAL IMPEDANCE AGGREGOMETER PROTOTYPE AND ADP LYOSPHERES TM by

  2021cites this paper
• Left Ventricular Assist Device Inflow Cannula Insertion Depth Influences Thrombosis Risk

  2019cites this paper
• Anti-thrombotic technologies for medical devices.

  2017cites this paper
• A multilevel study of platelet activation at biomaterial surface: from evaluatinhg to controlling hemocompatibility

  2016cites this paper
• Anticoagulant independent mechanical heart valves: viable now or still a distant holy grail.

  2016cites this paper
• Magnetic Devices and Techniques for the Study of Viscoelasticity of Biomaterials and Myocardial Forces

  2016cites this paper
• A Predictive Model of High Shear Thrombus Growth

  2016cites this paper
• Chapitre 9 – Place de la mécanique des fluides numérique dans les maladies cardio-vasculaires

  2015cites this paper
• Novel mediators and biomarkers of thrombosis

  2013cites this paper